- Shadow Work: How Businesses Are Turning Us All Into Unpaid Laborers
- IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price
- Carnival CEO Aims to Bust the Biggest Myths About the Cruise Industry
- Boomers' Biggest Retirement Regret? They Didn’t Work Longer
- The 10 Poorest States in America
The deal includes Oncaspar, a treatment for Acute Lymphoblastic Leukemia.
The provider of Web-based financial management software is not answering calls from private equity companies, says CEO Nick Fera.
For KPMG, the deal is its ninth in the past 17 months and its fourth in the health care space over that same period.
The private equity-backed Virtu Financial is setting its initial public offering range again, nearly a year after pulling a planned listing.
One analyst increased his buyout target to $14 for the hotel operator and believes the opportunity exists for a sale since the company now has positive cash flow.
These banks are set to reach the three-year anniversary of their initial public offerings, making them potential targets amid rampant consolidation in the industry.
Wesley Edens and Marc Lasry must sell the franchise back to the NBA for a below-market $575 million if the team does not find a new home arena by 2017.
When Mikhail Prokhorov bought the Nets in 2010, the Russian billionaire proclaimed that he had a five-year plan to bring an NBA championship to the team.
Mikhail Prokhorov and his minority shareholders are shopping the struggling team but not the wildly successful arena.
Healthcare information company Emdeon is exploring a potential IPO and is holding talks with banks. An IPO could value Emdeon upwards of $5.4 billion.